SYNAIRGEN PLC
SNG | IL
Overview
Corporate Details
- ISIN(s):
- GB00B0381Z20
- LEI:
- 213800IMMTOPPDF8HD24
- Country:
- United Kingdom
- Address:
- MAILPOINT 810 LEVEL F, SO16 6YD SOUTHAMPTON
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Synairgen is a respiratory biotech company developing inhaled interferon beta (IFN-_) for severe viral lung infections, aiming for a first-of-its-kind, broad-spectrum antiviral treatment delivered directly to the lungs [1].
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-16 08:00 |
Board/Management Change
Board and Executive Leadership Changes
|
English | 9.8 KB | |
| 2025-03-11 08:00 |
Regulatory News Service
Proposed cancellation of trading on AIM
|
English | 76.3 KB | |
| 2025-01-17 13:55 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.8 KB | |
| 2025-01-16 16:42 |
Regulatory News Service
Martin Murphy appointed as Non-Executive Director
|
English | 17.9 KB | |
| 2025-01-16 16:42 |
Declaration of Voting Results & Voting Rights Announcements
Result of General Meeting and Total Voting Rights
|
English | 13.5 KB | |
| 2025-01-15 18:37 |
Regulatory News Service
£18m raised to fund Phase 2 INVENT clinical trial
|
English | 14.8 KB | |
| 2024-12-20 08:00 |
Regulatory News Service
Proposed Fundraising
|
English | 398.7 KB | |
| 2024-10-30 19:09 |
Regulatory News Service
Exercise of Share Options and Total Voting Rights
|
English | 10.5 KB | |
| 2024-10-10 18:05 |
Declaration of Voting Results & Voting Rights Announcements
Results of AGM and Appointment of New Chairman
|
English | 10.8 KB | |
| 2024-09-26 08:00 |
Interim Report
Interim Results
|
English | 143.5 KB | |
| 2024-09-18 08:00 |
AGM Report
Appointment of New Chairman and Notice of AGM
|
English | 17.7 KB | |
| 2024-09-05 08:00 |
Regulatory News Service
Board Change
|
English | 11.1 KB | |
| 2024-06-27 08:00 |
Annual Report
2023 Full Year Results
|
English | 129.1 KB | |
| 2023-11-15 08:00 |
Directors' Dealings
Grant of Options
|
English | 28.7 KB | |
| 2023-10-11 08:00 |
Regulatory News Service
Appointment of New Chief Financial Officer
|
English | 17.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |